Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Hayden

Showing results (21-30 of 172) with videos related to

Pageof 18
Sort By:
Archives of Family Medicine|October 14, 2000
Picornavirus infections: a primer for the practitionerH A Rotbart, F G Hayden
Clinical Pharmacokinetics|August 3, 1999
Zanamivir. A potent and selective inhibitor of influenza A and B virusesF Y Aoki, F G Hayden
The Journal of Infectious Diseases|September 1, 1983
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illnessF G Hayden, J M Gwaltney
The Journal of Infectious Diseases|August 1, 1984
Intranasal interferon-alpha 2 treatment of experimental rhinoviral coldsF G Hayden, J M Gwaltney
Drugs|November 7, 1998
New approaches to influenza chemotherapy. Neuraminidase inhibitorsD P Calfee, F G Hayden
Infectious Disease Clinics of North America|June 1, 1987
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infectionsR L Tominack, F G Hayden
Antimicrobial Agents and Chemotherapy|April 1, 1988
Chemotherapy of rhinovirus coldsS J Sperber, F G Hayden
Journal of Clinical Microbiology|September 1, 1985
Comparative susceptibilities of strain MRC-5 human embryonic lung fibroblast cells and the Cooney strain of human fetal tonsil cells for isolation of rhinoviruses from clinical specimensF C Geist, F G Hayden
Journal of Interferon Research|June 1, 1989
Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -betaS J Sperber, F G Hayden
Infectious Disease Clinics of North America|December 1, 1995
Orthomyxoviral and paramyxoviral infections in transplant patientsC A Sable, F G Hayden
Pageof 18

Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
Archives of Family Medicine|October 14, 2000
Picornavirus infections: a primer for the practitionerH A Rotbart, F G Hayden
Clinical Pharmacokinetics|August 3, 1999
Zanamivir. A potent and selective inhibitor of influenza A and B virusesF Y Aoki, F G Hayden
The Journal of Infectious Diseases|September 1, 1983
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illnessF G Hayden, J M Gwaltney
The Journal of Infectious Diseases|August 1, 1984
Intranasal interferon-alpha 2 treatment of experimental rhinoviral coldsF G Hayden, J M Gwaltney
Drugs|November 7, 1998
New approaches to influenza chemotherapy. Neuraminidase inhibitorsD P Calfee, F G Hayden
Infectious Disease Clinics of North America|June 1, 1987
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infectionsR L Tominack, F G Hayden
Antimicrobial Agents and Chemotherapy|April 1, 1988
Chemotherapy of rhinovirus coldsS J Sperber, F G Hayden
Journal of Clinical Microbiology|September 1, 1985
Comparative susceptibilities of strain MRC-5 human embryonic lung fibroblast cells and the Cooney strain of human fetal tonsil cells for isolation of rhinoviruses from clinical specimensF C Geist, F G Hayden
Journal of Interferon Research|June 1, 1989
Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -betaS J Sperber, F G Hayden
Infectious Disease Clinics of North America|December 1, 1995
Orthomyxoviral and paramyxoviral infections in transplant patientsC A Sable, F G Hayden
Pageof 18